Psilocybin for Grief and Bereavement: The Emerging Research — click to play
Advertisement

Psilocybin for Grief and Bereavement: The Emerging Research

From MAPS on YouTube · 28:07 · Therapeutic Use

About This Video

Grief is one of the most universal human experiences — and one of the few psychological conditions for which psychiatry has historically offered no effective pharmacological intervention. While bereavement is not a clinical diagnosis, complicated grief disorder (also called prolonged grief disorder) is, affecting roughly 10% of bereaved individuals and associated with significant functional impairment, depression, and suicidality. This MAPS presentation reviews the emerging case for psilocybin-assisted therapy as an intervention for complicated grief.

The mechanistic argument is compelling. In complicated grief, the bereaved person is often unable to integrate the reality of the loss — the mind has difficulty updating its predictive model of the world to incorporate the absence of the person who was lost. Psilocybin's disruption of rigid predictive hierarchies (the REBUS model) may create a window in which this integration becomes possible.

Johns Hopkins grief pilot (n=12): participants received two psilocybin sessions with psychotherapy support. Participants described experiences of feeling the presence of the deceased, completing conversations, and a shift in their relationship to the loss — from frozen grief to a form of continuing presence. Clinical measures showed significant reductions in prolonged grief disorder symptoms at 6-month follow-up.

Key Takeaways

  • Complicated grief (prolonged grief disorder) affects roughly 10% of bereaved people and lacks effective pharmacological treatments — psilocybin is one of the first with a plausible mechanism.
  • The REBUS model hypothesis: psilocybin disrupts frozen predictive models of the world, potentially allowing integration of a loss the mind has been unable to process.
  • Johns Hopkins grief pilot (n=12) showed significant prolonged grief disorder symptom reductions at 6 months, with participants describing transformed relationships to their losses.
  • Psilocybin does not eliminate grief — it may transform the quality of grief from frozen, unprocessed loss to something more integrable.
  • Facilitators working with grief populations need specialized training — the relational vulnerability is distinct from depression or addiction work.

Dive Deeper

Continue exploring this topic on LearnShrooms:

Advertisement